tiprankstipranks
Trending News
More News >
Hawkins (HWKN)
NASDAQ:HWKN
Advertisement

Hawkins (HWKN) AI Stock Analysis

Compare
162 Followers

Top Page

HWKN

Hawkins

(NASDAQ:HWKN)

Rating:74Outperform
Price Target:
$183.00
▲(7.27% Upside)
Hawkins' overall stock score is driven by strong financial health and positive technical momentum, suggesting it is well-positioned in the specialty chemicals sector. However, the high P/E ratio and low dividend yield present some valuation concerns. Continued monitoring of financial performance and market conditions will be essential for potential investors.
Positive Factors
Revenue Growth
Consistent revenue growth indicates Hawkins' ability to expand its market reach and product adoption, supporting long-term business sustainability.
Balance Sheet Health
Low leverage provides financial stability and flexibility, allowing Hawkins to invest in growth opportunities and withstand economic fluctuations.
Segment Realignment
Realignment of segments can enhance operational management and resource allocation, potentially improving market positioning and stakeholder value.
Negative Factors
High Capital Expenditures
High capital expenditures, while supporting growth, can strain cash resources and require careful management to avoid impacting liquidity.
Valuation Concerns
A high P/E ratio can indicate overvaluation, potentially limiting stock price appreciation and making it less attractive to value-focused investors.
Dividend Yield
Low dividend yield may deter income-focused investors, impacting the attractiveness of Hawkins' stock as a long-term investment option.

Hawkins (HWKN) vs. SPDR S&P 500 ETF (SPY)

Hawkins Business Overview & Revenue Model

Company DescriptionHawkins, Inc. (HWKN) is a Minnesota-based company primarily engaged in the manufacturing and distribution of specialty chemicals and food ingredients. The company serves a diverse range of industries, including water treatment, pharmaceuticals, and food processing, providing essential products that enhance safety and efficacy in various applications. Hawkins operates through three main segments: Water Treatment, Industrial, and Healthcare, each offering a unique portfolio of products designed to meet the specific needs of its customers.
How the Company Makes MoneyHawkins generates revenue through the sale of its specialty chemicals and food ingredients across its three business segments. The Water Treatment segment contributes significantly to revenue by providing chemicals used in municipal and industrial water treatment processes. The Industrial segment focuses on specialty chemicals used in manufacturing and production processes for various industries, including agriculture and energy. The Healthcare segment supplies high-quality ingredients for pharmaceutical and nutraceutical applications. Revenue is driven by a combination of direct sales, long-term contracts with customers, and partnerships with distributors. Additionally, Hawkins benefits from economies of scale in production and logistics, allowing for competitive pricing and increased market share. Seasonal demand and regulatory changes in the water treatment industry also play a role in influencing revenue streams.

Hawkins Financial Statement Overview

Summary
Hawkins demonstrates solid financial health, with strong revenue growth, profitability, and cash flow generation. The income statement shows robust revenue and margin performance, the balance sheet reflects low leverage and strong ROE, and the cash flow statement highlights effective cash management despite high capital expenditures.
Income Statement
87
Very Positive
Hawkins has demonstrated strong growth in revenue, with TTM (Trailing-Twelve-Months) revenue increasing by 3.9% from the previous annual period. The gross profit margin stands at 23%, and the net profit margin is at 8.4%, indicating solid profitability. EBIT and EBITDA margins of 11.9% and 13.9% respectively also reflect efficient operations. The consistent revenue growth and healthy margins position Hawkins well in the specialty chemicals sector.
Balance Sheet
82
Very Positive
The company's balance sheet is robust with a debt-to-equity ratio of 0.04, showing low leverage. The equity ratio is 49%, indicating a strong capital structure. Return on equity (ROE) is a healthy 17.5%, showcasing effective use of shareholder equity to generate profits. The balance of debt and equity provides stability and financial flexibility, though maintaining this low leverage will be crucial to mitigate any future risks.
Cash Flow
78
Positive
Hawkins has shown positive free cash flow growth with a current TTM free cash flow of $81 million, up from $70 million in the previous period. The operating cash flow to net income ratio is 1.48, indicating strong cash flow generation relative to net income. The free cash flow to net income ratio of 0.96 highlights effective cash management. Despite high capital expenditures, the company maintains robust cash flow, supporting its operational and strategic initiatives.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.01B974.43M919.16M935.10M774.54M596.87M
Gross Profit233.25M225.54M193.64M165.12M146.52M123.76M
EBITDA154.50M159.76M137.23M117.23M95.51M79.99M
Net Income84.64M84.34M75.36M60.04M51.54M40.98M
Balance Sheet
Total Assets988.27M769.87M657.93M590.53M567.33M472.55M
Cash, Cash Equivalents and Short-Term Investments14.50M5.10M7.15M7.57M3.50M3.00M
Total Debt308.67M159.74M108.26M120.33M134.70M110.57M
Total Liabilities503.70M309.57M251.91M240.52M264.73M207.30M
Stockholders Equity484.57M460.29M406.03M350.02M302.60M265.25M
Cash Flow
Free Cash Flow81.01M70.00M119.35M29.08M14.32M23.00M
Operating Cash Flow125.00M111.10M159.50M77.40M42.84M43.79M
Investing Cash Flow-256.69M-127.95M-122.50M-41.23M-49.76M-71.43M
Financing Cash Flow137.31M14.81M-37.41M-32.10M7.42M26.36M

Hawkins Technical Analysis

Technical Analysis Sentiment
Positive
Last Price170.59
Price Trends
50DMA
164.96
Positive
100DMA
146.92
Positive
200DMA
131.16
Positive
Market Momentum
MACD
1.58
Positive
RSI
52.56
Neutral
STOCH
73.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HWKN, the sentiment is Positive. The current price of 170.59 is below the 20-day moving average (MA) of 170.75, above the 50-day MA of 164.96, and above the 200-day MA of 131.16, indicating a neutral trend. The MACD of 1.58 indicates Positive momentum. The RSI at 52.56 is Neutral, neither overbought nor oversold. The STOCH value of 73.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HWKN.

Hawkins Risk Analysis

Hawkins disclosed 22 risk factors in its most recent earnings report. Hawkins reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Hawkins Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$3.67B43.2318.69%0.43%9.51%5.20%
72
Outperform
$4.55B11.944.56%2.00%-6.73%
70
Neutral
$2.50B21.71-0.52%1.38%-3.09%-106.46%
63
Neutral
$2.12B113.001.55%1.96%-5.45%-87.13%
61
Neutral
$10.29B7.21-0.05%2.89%2.87%-36.73%
55
Neutral
$2.87B41.89-0.69%3.15%1.49%-105.20%
48
Neutral
$2.42B21.03-34.43%3.09%-11.38%-690.99%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HWKN
Hawkins
170.59
56.94
50.10%
ASH
Ashland
53.04
-29.09
-35.42%
IOSP
Innospec
83.08
-21.70
-20.71%
OLN
Olin
25.51
-14.09
-35.58%
KWR
Quaker Chemical
139.19
-18.60
-11.79%
SSL
Sasol
7.13
0.50
7.54%

Hawkins Corporate Events

Business Operations and Strategy
Hawkins Announces Realignment of Reporting Segments
Neutral
Aug 8, 2025

Hawkins, Inc. announced a realignment of its reporting segments effective from the first quarter of fiscal 2026 to better reflect organizational changes and its evolution into a specialty ingredients company. The new segments are Water Treatment, Food and Health Sciences, and Industrial Solutions, with the latter two incorporating businesses previously categorized under different segments. This strategic move is aimed at enhancing operational management and resource allocation, which could impact the company’s market positioning and stakeholder interests.

Executive/Board ChangesShareholder MeetingsBusiness Operations and Strategy
Hawkins Announces Board Election and Governance Updates
Neutral
Aug 1, 2025

At the annual meeting of shareholders on July 30, 2025, Hawkins company announced the election of eight directors to its Board, the ratification of Deloitte & Touche LLP as its independent public accounting firm for the fiscal year ending March 29, 2026, and the approval of executive compensation on a non-binding advisory basis. These decisions reflect the company’s ongoing governance and operational strategies, potentially impacting its future financial oversight and executive management policies.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 01, 2025